Neoplasms

Skin and Connective Tissue Diseases

All Conditions

Breast Neoplasms

Breast Diseases

Skin Diseases

Antineoplastic Agents

All Drugs and Chemicals

Angiogenesis Inhibitors

Sunitinib

Taxane

Growth Inhibitors

Protein Kinase Inhibitors

Enzyme Inhibitors

SU11248

hans wildiers, MD, PhD

This study tests the hypothesis that SU11248 can delay tumor progression after tumor mass reduction by taxanes. This is a dual-arm open-label randomized multicenter phase II clinical trial with 2:1 randomization evaluating the efficacy of SU11248 versus nil in patients with metastatic breast cancer after objective response to taxane chemotherapy. Patients randomized to the placebo arm (Arm B) will be offered the opportunity to receive open-label SU011248 treatment upon development of Response Evaluation Criteria in Solid Tumors (RECIST)-defined disease progression.

This study tests the hypothesis that SU11248 can delay tumor progression after tumor mass reduction by taxanes. This is a dual-arm open-label randomized multicenter phase II clinical trial with 2:1 randomization evaluating the efficacy of SU11248 versus nil in patients with metastatic breast cancer after objective response to taxane chemotherapy. Patients randomized to the placebo arm (Arm B) will be offered the opportunity to receive open-label SU011248 treatment upon development of RECIST-defined disease progression

SU11248 as Consolidation After Response to Taxanes in Metastatic Breast Cancer

A Belgian Multicenter Phase II Randomized Trial in her2 Negative Metastatic Breast Cancer Evaluating Consolidation Antiangiogenic Therapy With SU11248 After Response to Taxane Chemotherapy Induction

Pfizer

Universitaire Ziekenhuizen KU Leuven

adjunct head of clinic

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
SU11248 as Consolidation After Response to Taxanes in Metastatic Breast Cancer	NCT00270413	Metastatic Brea...	SU11248	18 Years -	Universitaire Ziekenhuizen KU Leuven
SU11248 as Consolidation After Response to Taxanes in Metastatic Breast Cancer	NCT00270413	Metastatic Brea...	SU11248	18 Years -	Universitaire Ziekenhuizen KU Leuven

Spots Global Cancer Trial Database for su11248

Every month we try and update this database with for su11248 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Spots Global Cancer Trial Database for su11248

Every month we try and update this database with for su11248 cancer trials from around the world to help patients and their families find trials that might be right for them. We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Every month we try and update this database with for su11248 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.